Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor primarily used for the treatment of erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. It functions by inhibiting the PDE5 enzyme, which results in increased levels of cyclic guanosine monophosphate (cGMP) leading to smooth muscle relaxation and vasodilation in the corpus cavernosum and pulmonary vasculature. Tadalafil is synthesized through various chemical routes, and its analogues have been developed to enhance its pharmacological profile. The gene location and structure are not directly applicable as tadalafil is a synthetic compound rather than a biological molecule. However, its mechanism of action involves interaction with the PDE5 enzyme, which is encoded by the PDE5A gene located on chromosome 4q27. Tadalafil's efficacy and safety have been demonstrated in clinical studies, particularly in combination with tamsulosin for improved management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
仅用于科研。不用于诊断过程。未经明确授权不得转售。